Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Small Cell Lung Carcinoma 3Carcinoma, Ovarian Epithelial 2Unspecified Adult Solid Tumor, Protocol Specific 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Meningeal Carcinomatosis 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Burkitt Lymphoma 1Brenner Tumor 1

Interventions

Cytarabine 25Etoposide 14tipifarnib 10Daunorubicin 10Mitoxantrone 9Idarubicin 7Azacitidine 6alvocidib 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Busulfan 5valspodar 4Vorinostat 4fludarabine phosphate 3aldesleukin 3Tretinoin 3Sorafenib 3Radiotherapy 3Gemtuzumab 3Cyclophosphamide 3Bortezomib 3tanespimycin 2sargramostim 2lintuzumab 2laromustine 2entinostat 2Watchful Waiting 2Topotecan 2Thioguanine 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Megakaryoblastic, Acute × trioctyl phosphine oxide × Clear all
NCT00634244 2015-07-07

Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
92 enrolled 10 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡